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AbstrAct
background Recent findings suggesting that Abelson 
helper integration site 1 (AHI1) is involved in non-
syndromic retinal disease have been debated, as the 
functional significance of identified missense variants 
was uncertain. We assessed whether AHI1 variants cause 
non-syndromic retinitis pigmentosa (RP).
Methods Exome sequencing was performed in three 
probands with RP. The effects of the identified missense 
variants in AHI1 were predicted by three-dimensional 
structure homology modelling. Ciliary parameters were 
evaluated in patient's fibroblasts, and recombinant 
mutant proteins were expressed in ciliated retinal 
pigmented epithelium cells.
results In the three patients with RP, three sets of 
compound heterozygous variants were detected in AHI1 
(c.2174G>A; p.Trp725* and c.2258A>T; p.Asp753Val, 
c.660delC; p.Ser221Glnfs*10 and c.2090C>T; 
p.Pro697Leu, c.2087A>G; p.His696Arg and c.2429C>T; 
p.Pro810Leu). All four missense variants were present 
in the conserved WD40 domain of Jouberin, the ciliary 
protein encoded by AHI1, with variable predicted 
implications for the domain structure. No significant 
changes in the percentage of ciliated cells, nor in cilium 
length or intraflagellar transport were detected. However, 
expression of mutant recombinant Jouberin in ciliated 
cells showed a significantly decreased enrichment at the 
ciliary base.
conclusions This report confirms that mutations in 
AHI1 can underlie autosomal recessive RP. Moreover, it 
structurally and functionally validates the effect of the 
RP-associated AHI1 variants on protein function, thus 
proposing a new genotype–phenotype correlation for 
AHI1 mutation associated retinal ciliopathies.
IntroductIon
Retinitis pigmentosa (RP) is a highly heteroge-
neous inherited retinal dystrophy characterised by 
progressive degeneration of photoreceptor cells 
primarily affecting the rods in early stages. Typical 
early signs of RP are night blindness and progressive 
loss of peripheral vision followed by visual acuity 
impairment at later stages and eventual blindness. 
RP is the most common form of inherited retinal 
dystrophy with a prevalence of 1 in 4000.1 Over 
2800 mutations in 81 genes have been implicated 
RP.2 Several genes associated with syndromic 
disease are also now implicated in non-syndromic 
RP (BBS1, USH2A, CLN3).3–5
Abelson helper integration site 1 (AHI1) was one 
of the first genes to be associated with Joubert 
syndrome (JBTS),6 7 a ciliopathy characterised by 
cerebellar vermis dysplasia accompanied by hypo-
tonia in infancy, developmental delay, abnormal 
eye movements and irregular respiratory pattern in 
infancy.8 Other features including retinal dystrophy, 
late onset nephronophthisis and polydactyly are 
only detected in a subset of patients and are often 
associated with the causative gene.8 Mutations in 
AHI1 are the most common genetic cause of JBTS 
and are often associated with retinal dystrophy 
and nephronopthisis as additional features in such 
patients.9 10
The AHI1 gene encodes the Jouberin protein, 
comprising a small predicted N-terminal coiled-coil 
domain, a WD40 repeat containing domain and a 
C-terminal SH3 domain, with multiple SH3-binding 
sites. This suggests that Jouberin may function as a 
scaffold protein, for example in protein complex 
assembly or cell signalling processes.6 Jouberin 
expression is ubiquitous, but highest in brain and 
testis and is regulated during development.7 11 At 
the subcellular level, Jouberin localises to ring-like 
structures at the transition zone of the primary 
cilium.12 Depletion of Ahi1 in vitro by siRNA in 
mouse kidney cell line IMCD3 causes a defect in 
ciliogenesis.13 Furthermore, Ahi1 knockout mouse 
models suffer from retinal degeneration caused by 
damage/defects in Rab8a-associated intracellular 
trafficking14 and Wnt-dependent cerebellar devel-
opment defects.15
Although there has been accumulative evidence 
supportive of an important function of Jouberin 
in the retina, only a single study has recently 
suggested AHI1 as a non-syndromic RP candi-
date gene based on next-generation sequencing 
data;16 and in the absence of functional valida-
tion, the pathogenicity of the variants reported 
were questioned.17 Here, we report the identifi-
cation of three patients with non-syndromic RP 
with compound heterozygous AHI1 mutations. To 
examine the pathogenicity of the detected AHI1 
variants, we assessed their effects via multiple in 
silico and in vitro techniques.
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MAterIAls And Methods
subjects and clinical evaluation
This study was approved by the institutional review boards of 
the participating centres and adhered to the tenets of the Decla-
ration of Helsinki. All participants provided informed consent.
A Dutch non-consanguineous family (family A) and two 
English non-consanguineous families (families B and C) each 
with one affected person with RP were included in this study 
(figure 1A). The Dutch patient (A-II:1) and English patients 
(B-II:2 and C-II:1) belong to larger cohorts of patients with 
visual impairment on whom Whole Exome Sequencing (WES) 
was performed. DNA samples of 209 RP probands of mainly 
Dutch ophthalmic centres were available.
Ophthalmological examinations were carried out on several 
occasions and the standard clinical examination included 
best-corrected visual acuity measurement using Snellen visual 
acuity charts and ophthalmoscopy. Colour vision was anal-
ysed using Hardy-Rand-Rittler and Ishihara colour vision test. 
Retinal fundus imaging was obtained by ultra-widefield confocal 
scanning laser image (Optos plc, Dunfermline, UK), 55 degree 
fundus autofluorescence (FAF) imaging (Spectralis, Heidel-
berg Engineering, Heidelberg, Germany) and Spectralis optical 
coherence tomography (OCT). A full field and pattern electro-
retinogram (ERG and PERG) were obtained in patients B-II:2 
and C-II:1 using gold foil electrodes and in patient A-II:1 using 
DTL electrodes according to International Society for Clinical 
Electrophysiology of Vision (ISCEV) standards.18 19 Visual filed 
testing was performed using a Humphrey Field Analyser (Carl 
Zeiss Meditec AG, Jena, Germany) or by Goldmann perimetry.
dnA analysis
Genomic DNA was isolated from leucocytes following stan-
dard procedures. Individual A-I:1 was deceased and DNA was 
extracted from paraffin-stored material.
WES of patient A-II:1 was performed at Beijing Genomics Institute 
(BGI)-Europe (Copenhagen, Denmark) using Agilent’s SureSelect XT 
Human All Exon V4 (Agilent Technologies, Santa Clara, California, 
USA), followed by sequencing on a HiSeq2000 next-generation 
sequencer (Illumina, San Diego, California, USA). At BGI, sequence 
reads were aligned to the human reference genome (GrCH37/hg19) 
using Burrows-Wheeler Aligner software and variant calling using 
Genome Analysis Toolkit (GATK) software. Variants were annotated 
using an in-house strategy. WES of patient B-II:2 and C-II:1 was 
performed at AROS Applied Biotechnology using a solution-phase 
Agilent SureSelect 38 Mb exome capture (SureSelect Human All 
Exon Kit; Agilent Technologies, Santa Clara, USA) and the Illumina 
HiSeq2000 sequencer (Illumina). Reads were aligned to the hg19 
human reference sequence (build GRCh37) using Novoalign V.2.08. 
Calling was performed using GATK software. Variants were anno-
tated using Annotate Variation (ANNOVAR) based on Ensembl gene 
and transcript definitions.
AHI1 exons were amplified from genomic DNA and Sanger 
sequenced using primers listed in supplementary tables. Sanger 
sequencing was used to confirm the detected variants to perform 
segregation analysis in family members, to exclude any addi-
tional variants in coding exons with a coverage below 10× in the 
WES data and to screen additional patients with RP for variants.
Modelling of Wd40 domain of Jouberin
The WD40 repeat protein structure predictor (WDSP) Jouberin 
WD40 domain structure (retrieved on June 2016 from http:// wu. 
scbb. pkusz. edu. cn/ wdsp/ getResults? id= 2328) was used to model 
the effect of the four ‘non-syndromic’ and seven ‘syndromic’ 
missense mutations and the retinal modifier on the structure of 
the WD40 domain.20–22 The protein model was loaded into the 
Yet Another Scientific Artificial Reality Application (YASARA) 
software, and images of the wild-type and mutant amino acid 
were made using the YASARA software.23
cdnA constructs
A synthetic cDNA construct of full-length human AHI1 isoform 
1 (Accession number AM393493), gateway adapted with 
Figure 1 AHI1 variants detected in three patients with non-syndromic retinitis pigmentosa; (A) pedigrees of three families with AHI1 variants. Filled 
symbols represent affected individuals, whereas open symbols represent unaffected individuals. The father in family A is deceased, depicted by the crossed 
box. The AHI1 genotype is depicted below each individual. M1: c.(2174G>A; 2488C>T) (p.(Trp725*; Arg830Trp)); M2: c.2258A>T (p.Asp753Val); M3: 
c.660delC (p.Ser221Glnfs*10); M4: c.2090C>T (p.Pro697Leu); M5: c.2087A>G (p.His696Arg) and M6: c.2429C>T (p.Pro810Leu). (b) Cross-species 
alignment of various organism spanning the regions containing the Jouberin amino acids p.D753, p.P697, p.H696 and p.P810.
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pENTR201 as a backbone vector, was purchased from Thermo 
Fisher Scientific (Catalogue no. FL1002). Site-directed mutagen-
esis, using Phusion (R) High-fidelity DNA polymerase (Bioke, 
the Netherlands) was performed to obtain the reference AHI1 
coding sequence (NM001134831.1) and to introduce four 
missense variants (c.2090C>T, c.2258A>T (current study), 
c.2156A>G and c.2173T>C (Joubert syndrome variants)). All 
resulting sequences were validated by Sanger sequencing. All 
N-terminal monomeric Red Fluorescent Protein (mRFP) fusion 
expressing constructs were generated using the Gateway cloning 
system (Life Technologies) and pDest-733 as the Destination 
expression vector (as previously described24). Primer sequences 
are available on request. The expression of all full-length mRFP 
fusion proteins in HEK 293 T cells was validated by immunoblot-
ting supplementary figure S5) using standard procedures, with 
anti-RFP antibodies (rabbit, ab62341 (Abcam); 1:1000 dilution 
in phosphate-buffered saline (PBS)) to stain recombinant mRFP, 
and antialpha tubulin antibodies (mouse, ab7291(Abcam); 
1:2000 dilution in PBS) to stain endogenous alpha-tubulin as a 
loading control.
Immunocytochemistry hTERT-RPE cells (ATCC) were plated 
at 25%–30% confluency in 12-well format and induced to form 
cilia by changing to starvation medium (Dulbecco's Modified 
Eagle Medium (DMEM)/F12 with 0.2% Fetal Calf Serum (FCS), 
1% Pen/Strep and 1% sodium pyruvate) after 24 hours. Expres-
sion plasmids containing sequences encoding either AHI1 wild-
type or mutants were transfected using lipofectamine according 
to manufacturer’s protocol (Thermo Fisher Scientific). Twen-
ty-four hours post transfection, cells were fixed in 2% PFA for 20 
min, permeablised in 1% TritonX100/PBS for 5 min and blocked 
in 2% Bovine Serum Albumin (BSA)/PBS for 30 min, sequen-
tially. Next, cells were incubated with primary antibody against 
ARL13B (ProteinTech; dilution 1:1000 in 2% BSA/PBS) for 
1 hour and then with secondary goat antirabbit-antibody Alexa 
Fluor 488 (Molecular Probes; dilution 1:500 in blocking buffer). 
Finally, cells were mounted on slide with vectashield containing 
DAPI (Brunschwig, The Netherlands). Slides were imaged using 
Axio Carl Zeiss Z2 with Apotome at ×63 magnification (Zeiss, 
Sliedrecht, The Netherlands). The experiment was repeated 
independently three times.
Fibroblast cells from RP patient A-II:1 (CL14-00043) 
and control individuals (male child CL10-00010, female 
adult CL09-00025and female adult 0 43 687) were plated at 
25%–30% confluency in 12-well format in standard DMEM with 
20% FCS and induced to form cilia by changing to starvation 
medium (DMEM/F12 with 0.2% FCS, 1% Pen/Strep and 1% 
Sodium Pyruvate) after 24 hours. Seventy-two hours post starva-
tion, cells were fixed in 2% PFA for 20 min, permeablised in 1% 
TritonX100/PBS for 5 min and blocked in 2% BSA/PBS for 30 
min, sequentially. Next, the staining procedure was the same as 
described above for hTERT-RPE cell with primary antibodies to 
the following proteins: Acetylated alpha-tubulin (mouse mono-
clonal, Life Technologies, dilution 1:1000), ARL13B (rabbit 
polyclonal, ProteinTech, dilution 1:500), RPGRIP1L (guinea 
pig polyclonal, SNC040, dilution 1:500),25 IFT88 (rabbit poly-
clonal, ProteinTech, dilution 1:100) and WDR19 (mouse poly-
clonal, Abnova, dilution 1:100). And these following secondary 
antibodies were used: antimouse IgG Alexa Fluor 568 and 488 
(1:500, Life Technologies), antirabbit IgG Alexa Fluor 568 and 
488 (1:500, Molecular Probes) and anti-guinea pig IgG Alexa 
Fluor 647 (1:500, Molecular Probes). Finally, cells were mounted 
on slide with vectashield containing 4',6-Diamidino-2-Phenylin-
dole (DAPI) (Brunschwig, The Netherlands). Slides were imaged 
using Axio Carl Zeiss Z2 with Apotome at ×63 magnification 
(Zeiss, Sliedrecht, The Netherlands).
Measurement and statistical analysis of signal intensity and 
ciliary length
For every AHI1 variant of each experiment, we measured the signal 
intensity of at least 25 cells. The mRFP signal channel was used to 
mark and measure the signal of Jouberin in the whole cell area. 
Both mRFP and green channel (ARL13B) were used to define and 
measure the signal of Jouberin at the base of the cilium. Corrected 
total cell fluorescence values were measured by intensity density, 
subtracted by the fluorescence signal of the background.
Cells with overexpression of different AHI1 proteins were 
evaluated for cilium formation and cilium length using Fiji Is Just 
ImageJ (FIJI). The mRFP and green channel for ARL13B were 
used to define cells with overexpression of AHI1 proteins and 
examine cilium formation. For cilium length analysis, the green 
channel (ARL13B staining) was processed using autothreshold. 
Finally, two plug-ins from FIJI (skeletonise and analyse skeleton, 
sequentially) were used to measure cilium length.
Pair-wise comparisons between wild-type versus mutants were 
analysed with unpaired two-tailed t-test using InStat. Signifi-
cance of pair-wise comparisons indicated as: ns,not significant, 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Results 
reported are from three independent biological replicates.
results
detection of AhI1 variants in non-syndromic retinal dystrophy 
patients
Family A
Patient A-II:1 was diagnosed with RP, prior screening of known 
recessive and dominant RP-associated variants via microarray 
(Asper Biotech) was negative and subsequently, WES was 
performed. The bases in the targeted region of the WES had a 
mean coverage of 103× and 94% of the bases in the targeted 
Figure 2 Ophthalmic images of the right eyes of patients with retinitis 
pigmentosa caused by AHI1 variants. (A, d and G) Fundus photographs; 
(b, e and h) fundus autofluorescence (FAF) images; (c, F and I) spectral-
domain optical coherence tomography images. (A, b and c) images of 
patient A-II:1; (d, e and F) images of patient B-II:2; (G, h and I) images of 
patient C-II:1.
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region had a coverage >30×, the WES yielded 1 22 737 variants. 
Variants in a panel of 299 genes involved in non-syndromic and 
syndromic visual impairment were examined, yielding 2041 vari-
ants, of which 11 were coding or in the splice site region (20 bp of 
the splice acceptor and donor site) and had a frequency of ≤1% 
in Single-Nucleotide Polymorphism database (dbSNP) and in 
an in-house exome database, containing results of 5036 exomes 
(10 072 alleles) of primarily Dutch individuals. The only plausible 
disease causing variants were two heterozygous variants in AHI1 
c.2174G>A; p.Trp725* and c.2258A>T; p.Asp753Val (online 
supplementary table S2). This patient had an additional third 
variant in the AHI1 gene c.2488C>T; p.Arg830Trp; however, due 
the high frequency of this variant in control populations (3.85% 
Exome Aggregation Consortium (ExAc) (0.3.1)), it was considered 
not to be disease causing. Furthermore, segregation analysis deter-
mined that the c.2488C>T variant is on the same haplotype as the 
non-sense variant c. 2174G>A located upstream (figure 1A).
The c.2174G>A; p.Trp725* nonsense variant occurs in exon 
16 of 29 and would be predicted to undergo nonsense-mediated 
decay (NMD), thus representing a null mutation. The missense 
mutation, c.2258A>T; p.Asp753Val, was previously unreported 
in JBTS and absent from the ExAC data set and from the 10 072 
alleles of in-house exomes of primarily Dutch individuals and 
alters a highly conserved amino acid within the WD40 repeat 
region (figure 1B) and was predicted damaging in silico (online 
supplementary table S3).
Family B
Patient B-II:2 underwent WES to determine the genetic basis of 
her RP. The bases in the targeted region of the WES had a mean 
coverage of 90×. WES revealed 22 554 variants that passed stan-
dard quality filter, of which 394 had a minor allele frequency 
(MAF) ≤0.005 in the National Heart Lung Blood Institute 
(NHLBI) GO Exome Sequencing Project (URL: http:// evs. gs. 
washington. edu/ EVS/ release 13 May 2013) and an in-house 
exome sequencing cohort of over 4000 individuals (UCLex) and 
were coding or in the splice region (5 bp of the splice acceptor 
Figure 3 Disease-causing missense mutations in Jouberin. (A) Localisation of the missense mutations in Jouberin. Open box depicts coiled coin domain, 
light grey boxes depict the seven repeats of the WD40 domain and the dark grey box depicts the SH3 domain. Missense variants detected in patients with 
non-syndromic retinitis pigmentosa are depicted in the upper part, while missense variants detected in JBTS patients are depicted in the bottom part. (b) 
Predicted effect of the amino acid change of non-syndromic RP (p.His696Arg, p.Pro697Leu, p.Asp753Val and p.Pro810Leu) and JBTS missense variants 
(p.Asp719Gly and p.Trp725Arg) in a protein homology model of the WD40 domain of Jouberin. In green the wild-type amino acids, in magenta the amino 
acid changes of a non-syndromic RP-associated missense variants and in cyan the amino acid changes of a JBTS-associated missense variants are depicted. 
JBTS, Joubert syndrome; RP, retinitis pigmentosa.
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and donor site). Regarding autosomal recessive inheritance, 
seven genes had ≥2 variants, of which, AHI1 was the most 
plausible candidate (online supplementary table S2). Segrega-
tion analysis confirmed the compound heterozygous genotype 
(figure 1A).
The frameshift variant c.660delC; p.Ser221Glnfs*10 occurs 
in exon 7 of 29 and is expected to represent a null allele due 
to NMD. The c.2090C>T; p.Pro697Leu missense variant was 
also absent from in-house and ExAC variant databases and alters 
a highly conserved amino acid within the WD40 repeat region 
(figure 1B), and was predicted damaging in silico (online supple-
mentary table S3).
Family C
Patient C-II:1 underwent WES to determine the genetic basis of 
her RP. The bases in the targeted region of the WES had a mean 
coverage of 38×. WES revealed 23 003 variants that passed a 
standard quality filter, of which 936 had an MAF ≤0.005 in the 
NHLBI GO Exome Sequencing Project and an in-house exome 
sequencing cohort of over 4000 individuals (UCLex), and were 
coding or in the splice region (5 bp splice acceptor and donor 
site). Regarding autosomal recessive inheritance, 15 genes had 
≥2 variants, of which, AHI1 was the most plausible candidate 
(online supplementary table S2). Segregation analysis confirmed 
the compound heterozygous genotype (figure 1A). Both the 
c.2087A>G; p.His696Arg and c.2429C>T; p.Pro810Leu 
missense variants were absent from in-house and ExAC variant 
databases, alter highly conserved amino acids in the WD40 
repeat region (figure 1B), and were predicted damaging in silico 
(online supplementary table S3).
Additional screening of a cohort of 209 patients with rP
Patients in all three of the above families carried at least one 
AHI1 allele with a missense mutation in the WD40 domain 
(WD40 repeat 3, 4 or 5). We hypothesised that non-syndromic 
RP may be associated with mutations in the WD40 repeat region 
of AHI1, and therefore screened a cohort of 209 RP probands 
for variants in exon 16–19 of AHI1 (encompassing WD40 repeat 
3 until 6) by Sanger sequencing. No plausible pathogenic variants 
Figure 4 AHI1 variants do not impair core ciliary parameters in patient's fibroblasts. Primary cilia from patient with retinitis pigmentosa A-II:1 fibroblasts 
(CL14-00043) did not differ from control fibroblasts (CL043687, CL09-00025 and CL10-00010) in terms of percentage of ciliated cells (A) and length of 
the cilia (b). There is also no significant difference in overall distribution of IFT88 (c) and WDR19 (d) along the cilium. The graph is representative for three 
independent repeated experiments. Representative images of the immunocytochemistry experiments are shown in supplementary figures.
Figure 5 RP-associated and Joubert syndrome-associated missense 
variants in AHI1 caused a significant decrease in Jouberin enrichment to 
the basal bodies of cilia in hTERT-RPE1 cells, compared with wild-type 
Jouberin (A). *** The p value<0.0001 using unpaired t-test. Values of 
means±SE are provided in supplementary table S6. (b–F) Representative 
images of the localisation of wild-type (b) and mutant (c–F) Jouberin/AHI1 
protein (red) at the ciliary base of hTERT-RPE1 cells by immunofluorescence. 
ARL13B (green) was used as a marker for the primary cilium. RP, retinitis 
pigmentosa.
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were identified. Three polymorphisms were observed with MAF 
too high in control datasets to be considered pathogenic alleles 
(online supplementary table S4).
clinical evaluations
Invariably, all patients were developmentally normal at last 
review ages 38 to 55 years. Specifically, none of the patients had 
symptoms or signs of cerebellar ataxia or hypotonia. No patient 
had undergone neuroradiological imaging as there was no clin-
ical indication. All three patients had normal renal investigations 
comprising renal ultrasound and serum urea, creatinine and elec-
trolytes.
ophthalmic examinations of patient A-II:1, b-II:2 and c-II:1
Clinical data of patients A-II:1, B-II:2 and C-II:1 are summarised 
in supplementary tables.
Patient A-II:1 was diagnosed with RP at the age of 53 years. 
In retrospect, she was aware of dark adaptation problems since 
the age of 20 years, but experienced night blindness only since 
the age of 47 years. Despite quite pronounced macular changes 
on ophthalmoscopy and FAF (figure 2A,B), her visual acuity was 
still 1.0 and 0.8 at recent examination with preserved outer retinal 
layers on OCT (figure 2C). Goldmann perimetry revealed an alti-
tudinal defect of the upper quadrants with midperipheral absolute 
scotomas in the lower quadrants. Full-field ERG showed a barely 
recognisable rod response (mainly in the right eye) with still rela-
tively well preserved cone derived responses in both eyes.
Patient B-II:2 developed nyctalopia in her 20s with progres-
sive restriction of visual fields. At the age of 27 years, visual 
acuity was R 6/36 Snellen, L 6/24 with refractive correction 
of R −7.75 dioptre sphere (DS) and L −7.50 DS. Vision had 
deteriorated to hand movements vision in each eye by the age 
of 33 years. Bilateral cataract surgery was performed and at 
last review age 39 vision was 1/60 each eye with fields reduced 
to less than the central 5 degrees. Dilated fundus examination 
identified pale discs, attenuated vessels and widespread retinal 
atrophy, without hyperpigmentation in both eyes (figure 2D), 
and in addition a circular chorioretinal atrophic lesion in the 
left macula. There was generalised loss of autofluorescence 
corresponding to atrophic regions, with small islands of central 
hyperautofluorescence remaining in the macula (figure 2E). OCT 
demonstrated a degeneration of the outer retina (figure 2F). 
Electrophysiology at the age of 27 years demonstrated a moder-
ate-to-severe generalised retinal dysfunction involving both rod 
and cone systems.
Patient C-II:1 developed nyctalopia at the age of 37 years 
with subjective deterioration over time and the development 
of restricted peripheral visual fields. At last review at the age 
of 41 years, VA was R 6/12 and L 6/9 with myopic refrac-
tive correction. Colour vision testing demonstrated a mild 
red-green colour defect (Hardy-Rand-Rittler (HRR) plates). 
On dilated examination, posterior subcapsular cataracts were 
present in both eyes. There were myopic fundus changes (tilted 
discs and peripapillary atrophy) and disc pallor with periph-
eral intraretinal pigment migration (figure 2G). FAF imaging 
demonstrated a ring of increased autofluorescence in both 
maculae, with reduced autofluorescence in the midperipheral 
retina (figure 2H). OCT imaging demonstrated a preserved 
central inner segment ellipsoid band (figure 2I). At the age of 
38 years, electrophysiology was consistent with a moderate 
to severe generalised retinal dysfunction of rods slightly more 
than cones, with the right eye slightly more affected than the 
left eye.
In silico evaluation of the pathogenicity of the missense 
variants
To predict the effect of the detected AHI1 variants, we performed 
three-dimensional structure homology modelling of wild-type and 
mutant Jouberin. The Jouberin protein contains a WD40 domain, 
consisting of seven WD40 repeats within its C-terminal half (aa 
607–926) and an SH3 domain close to the C terminus (aa 1051–
1111). All four missense variants reported herein are located within 
the WD40 domain (figure 3A). Interestingly, 7 of the 11 missense 
variants that have been implicated to cause Joubert syndrome are 
also located in the WD40 domain, indicating the importance of the 
WD40 domain in the proper function of Jouberin (figure 3A). The 
only missense variant with a frequency above 1% in the WD40 
domain of Jouberin in the ExAc database, the p.Arg830Trp variant, 
has been described as a retinal modifier in Joubert patient with a 
non-AHI genetic cause. The predicted secondary structure of the 
Jouberin WD40 domain was used to model the effect of the four 
‘non-syndromic’ and seven ‘syndromic’ missense mutations and 
the retinal modifier. The p.Thr671Ile, p.His696Arg, p.Asp719Gly, 
p.Arg723Gln, p.Trp725Arg and p.Ser761Leu most likely disrupt 
the WD40 structure, because these amino acids changes are at 
essential positions in the core of their respective WD40 repeat 
motif (figure 3B and supplementary figure S1). The p.Ile641Asn, 
p.Pro697Leu, p.Asp753Val, p.Arg830Trp and p.His896Arg are 
predicted to have a milder effect on the WD40 structure because 
these amino acid residues are located at the surface of their respec-
tive WD40 repeat motif. These changes, however, do have a local 
effect on the stability of the domain in which they are located 
(figure 3B and supplementary figure S1). The p.Pro810Leu substi-
tution is predicted to have no clear effect on the WD40 struc-
ture, the residue is located at the surface of WD40 repeat 5 and 
the substitution of the hydrophobic proline with a hydrophobic 
leucine does not seem to have any effect on the WD40 structure 
itself (figure 3B). However, the mutated residue might play an 
important role in the interaction with other proteins.
rP-associated AHI1 variants do not affect core cilium 
parameters of fibroblasts
To determine the effect of the identified missense variants on 
the cilium function of Jouberin, we compared primary cilium 
formation of patient A-II:1-derived fibroblasts with control 
fibroblasts. The fibroblasts were cultured in starvation condition 
to induce ciliogenesis. Approximately 90% of both control and 
A-II:1 patient-derived fibroblasts were able to form a primary 
cilium (figure 4A, supplementary figure S2B). The primary 
cilia length did not differ from controls, that is, approximately 
4.88±1.5 µm in patient-derived cells versus 4.83±1.22 µm in 
controls (figure 4B, supplementary figure S2A,C).
In addition, we evaluated intraflagellar transport (IFT) in the 
fibroblasts of patient A-II:1 by IFT88 (IFT-B, supplementary 
figure S2A,B) and WDR19/IFT144 (IFT-A, supplementary figure 
S2C,D) immunostaining. We observed no significant difference 
in the overall distribution of IFT88 and WDR19 along the cilium 
(base, base + tip and base + axoneme) between RP patient-de-
rived and control fibroblasts (figure 4C,D).
rP-associated AHI1 missense mutations decrease its 
enrichment at the basal body
To evaluate the effect of the detected AHI1 variants on locali-
sation of Jouberin to the ciliary base, we overexpressed mRFP 
fusion proteins of wild-type and mutant AHI1/Jouberin in 
immortalised retinal pigmented epithelium cells (hTERT-RPE 
cells). We selected two missense mutations c.2090C>T. 
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(p.Pro697Leu) and c.2258A>T (p.Asp753Val) detected in 
patients with non-syndromic RP; and also included two JBTS-as-
sociated missense variants c.2156A>G (p.Asp719Gly) and 
c.2173T>C (p.Trp725Arg), located within the WD40 domain, 
to evaluate whether there is any different effect on AHI1 locali-
sation between RP-associated variants and JBTS-associated ones.
Wild-type mRFP-AHI1 showed a diffused cytoplasmic local-
isation and a strong enrichment at the ciliary base of ciliated 
hTERT-RPE1 cells (figure 5A,B and supplementary figure S3A). 
Although RP-associated mutant Jouberin was still able to localise 
to the ciliary base, we observed a significant decrease of this 
enrichment compared with the wild-type protein (figure 5A,C,D 
and supplementary figure S3B,C). Interestingly, the localisation 
of JBTS-associated mutant Jouberin showed a similar difference 
compared with the wild-type protein, but it was not different 
from the RP-associated mutant Jouberin (figure 5A,E,F and 
supplementary figure S3D,E). Results of staining of the ciliary 
protein ARL13B, used as a marker for cilia in these experiments, 
were also used to assess any effects of overexpression of the 
recombinant mutated Jouberin on ciliogenesis. Neither ciliary 
frequency nor cilium length varied significantly (online supple-
mentary figure S4).
dIscussIon
It is well established that mutations in AHI1 cause JBTS due to 
disruption of cilium formation and function in ciliated cells of 
diverse tissues in the body. In this study, we identified compound 
heterozygous mutations in AHI1 in three patients with non-syn-
dromic RP. Five of the identified mutations are novel while one 
(c.2174G>A; p.Trp725*) has been identified in patients with 
JBTS with two deleterious AHI1 variants.26 The patients had a 
relatively late onset of RP and the disease progression was mild 
in all three patients. No other clinical features of JBTS were 
evident in the patients. Although no neurological imaging was 
performed, the lack of any of the syndromic clinical characteris-
tics at the advanced age of all three patients makes the presence 
of a mild form of JBTS in the patients unlikely.
Thirty-nine of 48 reported variants in AHI1 in patients with 
JBTS are presumed loss of function. The remaining nine missense 
(of which seven are located within the WD40 domain and three 
before the WD40 domain) were observed in a homozygous state 
in typical patients with JBTS, suggesting they have a severe effect 
on the Jouberin protein localisation and/or function, which has 
indeed been shown for the p.Val443Asp variant.27
Using homology modelling, we show that of the seven 
Joubert-associated missense mutations, four have a predicted 
severe effect and two have a mild effect on the WD40 struc-
ture, while of the four non-syndromic retinal dystrophy missense 
mutations one has a severe, two have a mild and one has no clear 
effect on the WD40 structure. This indicates that most likely 
missense mutations detected in patients with Joubert syndrome 
have a more disruptive effect on the WD40 structure compared 
with the missense mutations detected in patients with non-syn-
dromic RP.
Two of the patients with RP described here carry a loss-of-func-
tion allele and a missense variant affecting a conserved amino 
acid residue of the WD40 domain, and the third patient carries 
a predicted severe missense in trans with a milder mutation in 
the WD40 domain. We hypothesise that patients with Joubert 
syndrome have two severe AHI1 mutations that completely 
disrupt Jouberin function, while our patients with non-syn-
dromic RP have one severe and one mild mutation and most 
likely have some remaining Jouberin activity. The remaining 
Jouberin activity seems to be sufficient for proper ciliary func-
tion in all relevant tissues, except for the retinal photoreceptor 
cells. A similar tissue-dependent activity-effect model was 
also suggested for other genes, for instance CLN3, CEP290, 
HGSNAT and MFSD8 that can be associated with syndromic and 
non-syndromic retinal diseases.28–31
The hypothesis that the missense variants in the WD40 
domain do not completely abolish Jouberin function is further 
supported by our observation that cultured fibroblasts of patient 
A-II:1 (c.2174G>A and c.2258A>T) had no disrupted cilium 
formation, while Tuz et al showed that mutations in individuals 
with JBTS cause impaired ciliogenesis in patient’s fibroblasts.27 
Additionally, we did not observe mislocalisation of either IFT-B 
(IFT88) or IFT-A (WDR19), a phenotype that was previously 
detected in other severe ciliopathies.32–35
Moreover, on expression of the recombinant proteins, the 
RP-associated variants cause a decreased enrichment of Jouberin 
at the ciliary basal bodies compared with the wild-type protein. 
This could be due to improper folding of protein leading to 
destabilisation of mutant Jouberin or due to interference of the 
protein interaction which is necessary to target Jouberin to the 
basal body. Intriguingly, JBTS-associated AHI1 mutations within 
the WD40 domain have a similar distortion of the ability of 
Jouberin to localise to the basal body. This suggests that pheno-
typic differences of RP versus JBTS might not be primarily due to 
mislocalisation of AHI1 mutants, but rather to a more tissue-spe-
cific loss of protein function, such as interaction with a partic-
ular protein or protein complex in which Jouberin is active, 
presumably at the described ring-shaped domain at the cilium–
centriole interface.12 Alternatively, as the frequent AHI1 variant 
p.Arg830Trp has been described to be a genetic modifier for 
retinal degeneration in nephronophthisis, other epistatic inter-
actions outside of the retina could also potentially be important 
either in exacerbation of the syndromic JBTS phenotype or in 
protection against it.
Our results suggest that the identified AHI1 variants in 
patients with RP might not disrupt the essential role of Jouberin 
in ciliogenesis nor its role in axonemal IFT trafficking, but 
rather mildly affect IFT balance or docking/undocking at the 
ciliary base without causing major ciliary defects, which is in 
line with the comparatively mild RP phenotype. This hypoth-
esis is further supported by the proposed function of Jouberin 
as scaffold protein at the ciliary transition zone.12 36 37 AHI1 
was already implicated to cause non-syndromic RP in a single 
patient who underwent WES. However, the pathogenicity of the 
detected AHI1 variants was questioned and further experiments 
were needed to assess the role of AHI1 in non-syndromic RP. 
As exome sequencing or screening of gene panels is now being 
performed on a regular basis, it remains of critical importance 
to perform an extensive evaluation of the pathogenicity of rare 
variants. Even more when functional evidence about the asso-
ciation with a specific disease phenotype has remained elusive, 
which was recently highlighted in Heller et al.17 We detected 
three additional patients with compound heterozygous AHI1 
mutations and combined with our functional data identified a 
new genotype–phenotype correlation for AHI1. With the broad 
use of WES, additional novel AHI1 variants will be detected that 
proposes a challenge in terms of how to investigate and distin-
guish the molecular mechanism by which AHI1 mutations cause 
RP versus JBTS, as well as emphasises the necessity in careful 
evaluation and validation of the pathogenicity of newly iden-
tified AHI1 variants in light of the presented clinical data. This 
knowledge is critically important to avoid the false interpreta-
tion of variants. In family C of this study, the pathogenicity of 
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the detected variants in AHI1 (c.2087A>G; p.His696Arg and 
c.2429C>T; p.Pro810Leu) were determined using in silico 
prediction models. To ensure these variants are disease causing, 
additional functional tests should be performed.
In conclusion, we determined that variants in the AHI1 gene 
can cause non-syndromic RP next to Joubert syndrome. Interest-
ingly, patients with RP and with pathogenic AHI1 variants have 
a late onset of disease and mild progression. We hypothesise that 
the AHI1 variants that cause RP most likely give rise to residual 
Jouberin function that can overcome all symptoms of Joubert 
syndrome, except for retinal degeneration.
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